Effects of laser treatment and indirect moxibustion in knee osteoarthritis

Not Applicable

• Conditions: KNEE OSTEOARTHRITS; C05.550.114.606 C05.799.613

• Registration Number: RBR-3kmpr6s
• Lead Sponsor: niversidade Brasil

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-08-30
• Study Start: 2021-06-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

To be included in the study, the patient / volunteer must accept to participate in the research (signing the informed consent form); be diagnosed with OAJ with levels of 2 - 4 according to the degree of Kellgren and Lawrence in the x-ray exam, evaluated by the orthopedists of the unit (21); be aged between 45 and 80 years; knee pain and functional disability for at least three months; and medical indication to perform physiotherapeutic treatment. Without a history of local medications or surgeries for at least 12 months and without the use of medication with continuous systemic effects, such as analgesics, anti-inflammatories, chondroprotectors, corticosteroids, NSAIDs, for treatment for at least 90 days, being guided by the doctors of the unit not to use these medications.

Exclusion Criteria

Not participate in the study, patients / volunteers that have full or partial prosthesis in one or both knees or hips; symptomatic hip osteoarthrosis, knee ankylosis; cancer; neurological diseases that affect locomotion; they will also be exclusion criteria, and that after the invitation, they do not feel safe, embarrassed and / or pressured to participate in the research. Patients who underwent local infiltrations for less than 12 months, patients who underwent surgical interventions on the knee for less than 12 months, patients using analgesic medications, NSAIDs, corticosteroids, chondroprotectors for less than 90 days.
Patients with some type of comorbidity who need any of the above types of medication, as well as patients with severe and / or decompensated cardiovascular diseases, patients with decompensated Diabetes Mellitus, rheumatological diseases.

Study & Design

• Study Type: Intervention
• Study Design: Not specified